Abstract
Introduction: Mesenchymal stem cells (MSCs) have been known to have angiogenic potency, particularly for wound healing. However, it is such a cumbersome procedure to obtain a large amount of MSCs due to the culture process. The stromal vascular fraction (SVF), or so called nonexpanded MSCs, of adipose tissue is gaining increased interest in the field of cell therapy. An optimized method that takes only 2 hours to produce a large amount of stromal cells from adipose tissue has been developed. Burn wound model was used to assess the efficacy of SVF produced by our method. This study aimed to evaluate the efficacy of SVF compared to MSCs. Methods: Male Sprague-Dawley rats with second degree burn wound were divided into the study groups: SVF, MSCs and saline control. The wound was photographed and evaluated weekly up to 5 weeks. The comparative analysis consisted of healing time, histology of skin tissue, as well as rat and human vascular endothelial growth factor (VEGF) expression. Results: In this study, wounds treated with SVF and MSCs were smaller after 14-21 days, compared to the untreated group. Expression of rat VEGF in SVF and MSC- treated groups after seven days post-wounded were also higher than the untreated group. No human VEGF was found expressed in the skin biopsies. Conclusion: This suggests that SVF and MSCs promote wound healing via a paracrine effect. The results suggest that SVF may be useful for wound healing and may be used as a promising alternative to MSC-based therapy.
Highlights
Mesenchymal stem cells (MSCs) have been known to have angiogenic potency, for wound healing
We investigated the efficacy of stromal vascular fraction (SVF) for burn wound healing in a rat model, with adiposederived MSCs (AD-MSCs) used in the comparison
The resultant Complementary DNA (cDNA) was subjected to quantitative real-time polymerase chain reaction (PCR) performed using
Summary
Mesenchymal stem cells (MSCs) have been known to have angiogenic potency, for wound healing. It is such a cumbersome procedure to obtain a large amount of MSCs due to the culture process. The comparative analysis consisted of healing time, histology of skin tissue, as well as rat and human vascular endothelial growth factor (VEGF) expression. Determining optimal cell dose is important for successful cell therapy Koga and his coworkers demonstrated that a dosage of 50 million MSCs per mL injected into cartilage defects in rabbit was a superior dose than 1 million MSCs per mL for cartilage repair 3. Rat and human VEGF expression were measured to evaluate the angiogenic potency of SVF and MSCs
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have